Suppr超能文献

基于网络药理学策略探索京银颗粒抗肺纤维化的机制

Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy.

作者信息

Zhu De-Wei, Yu Qun, Jiang Mei-Fang, Wang Dan-Dan, Shen Yun-Hui

机构信息

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

SPH Xing Ling Sci. & Tech. Pharmaceutical Co., Ltd., Shanghai, China.

出版信息

Front Pharmacol. 2022 Feb 11;13:825667. doi: 10.3389/fphar.2022.825667. eCollection 2022.

Abstract

Pulmonary fibrosis (PF) is a clinically common disease caused by many factors, which will lead to lung function decline and even respiratory failure. Jingyin granule has been confirmed to have anti-inflammatory and antiviral effects by former studies, and has been recommended for combating H1N1 influenza A virus (H1N1) infection and Coronavirus disease 2019 (COVID-19) in China. At present, studies have shown that patients with severe COVID-19 infection developed lung fibrotic lesions. Although Jingyin granule can improve symptoms in COVID-19 patients, no study has yet reported whether it can attenuate the process of PF. Here, we explored the underlying mechanism of Jingyin granule against PF by network pharmacology combined with experimental validation. In the present study, the active ingredients as well as the corresponding action targets of Jingyin granule were firstly collected by TCMSP and literature data, and the disease target genes of PF were retrieved by disease database. Then, the common targets were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, and then a PPI network and an ingredient-target network were constructed. Next, UPLC-MS was used to isolate and identify selected representative components in Jingyin granule. Finally, LPS was used to induce the A549 cell fibrosis model to verify the anti-PF effect of Jingyin granule . Our results indicated that STAT3, JUN, RELA, MAPK3, TNF, MAPK1, IL-6, and AKT1 were core targets of action and bound with good affinity to selected components, and Jingyin granule may alleviate PF progression by Janus kinase 2/signal transducers and activators of transcription (JAK2/STAT3), the mammalian nuclear factor-κB (NF-κB), the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), tumor necrosis factor (TNF), and the extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling pathways. Overall, these results provide future therapeutic strategies into the mechanism study of Jingyin granule on PF.

摘要

肺纤维化(PF)是一种由多种因素引起的临床常见疾病,会导致肺功能下降甚至呼吸衰竭。既往研究已证实荆银颗粒具有抗炎和抗病毒作用,在中国已被推荐用于对抗甲型H1N1流感病毒(H1N1)感染和2019冠状病毒病(COVID-19)。目前,研究表明严重COVID-19感染患者会出现肺纤维化病变。虽然荆银颗粒可改善COVID-19患者的症状,但尚无研究报道其是否能减轻PF进程。在此,我们通过网络药理学结合实验验证来探究荆银颗粒抗PF的潜在机制。在本研究中,首先通过中药系统药理学数据库与分析平台(TCMSP)和文献数据收集荆银颗粒的活性成分及其相应作用靶点,并通过疾病数据库检索PF的疾病靶基因。然后,对共同靶点进行基因本体论(GO)和京都基因与基因组百科全书(KEGG)富集分析,接着构建蛋白质-蛋白质相互作用(PPI)网络和成分-靶点网络。接下来,采用超高效液相色谱-质谱联用(UPLC-MS)分离并鉴定荆银颗粒中选定的代表性成分。最后,使用脂多糖(LPS)诱导A549细胞纤维化模型来验证荆银颗粒的抗PF作用。我们的结果表明,信号转导与转录激活因子3(STAT3)、原癌基因蛋白c-Jun(JUN)、维甲酸诱导蛋白(RELA)、丝裂原活化蛋白激酶3(MAPK3)、肿瘤坏死因子(TNF)、丝裂原活化蛋白激酶1(MAPK1)、白细胞介素-6(IL-6)和蛋白激酶B(AKT1)是作用的核心靶点,且与选定成分具有良好的亲和力,荆银颗粒可能通过 Janus激酶2/信号转导与转录激活因子(JAK2/STAT3)、哺乳动物核因子-κB(NF-κB)、磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)、肿瘤坏死因子(TNF)以及细胞外信号调节激酶1和2(ERK1/2)信号通路减轻PF进展。总体而言,这些结果为荆银颗粒对PF作用机制的研究提供了未来的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1176/8874130/3b1603c7157a/fphar-13-825667-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验